| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $2.70B | +2.9% |
| Gross profit | $0.89B | — |
| Operating income | $0.07B | — |
| Net income | $-0.01B | -111.9% |
| Gross margin | 33.0% | Net margin -0.6% |
| Segment | Revenue | Share |
|---|---|---|
| US | $0.53B | 19.5% |
| Non Us | $0.46B | 16.8% |
| Care And Connectivity Solutions | $0.43B | 16.1% |
| Pharmaceutical Compounding | $0.32B | 11.8% |
| Advanced Surgery | $0.30B | 11.3% |
| Injectables And Anesthesia | $0.30B | 11.1% |
| Front Line Care | $0.27B | 10.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $1.81B | 67.0% |
| R&D | $0.14B | 5.1% |
| SG&A | $0.73B | 27.0% |
| Tax & other | $0.08B | 3.0% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
BDX ・ BRK.B ・ BBY ・ TECH ・ BIIB ・ BLK ・ BX ・ XYZ ・ BNY ・ BA ・ BKNG ・ BSX
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies